Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-09

FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for trazodone hydrochloride by Teva Pharmaceuticals USA, Inc., authorizing changes to the product labeling under an …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trazodone hydrochloride (Trazodone hydrochloride)

Snippet

SUPPL AP for TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)